Other Open Access
PREFER Recommendations - Why, when and how to assess and use patient preferences in medical product decision-making
The PREFER consortium
Two key uses of patient preference information are to inform the choice of patient-relevant endpoints by providing information on the relative importance of what matters to patients, and to provide information on patients’ views about the acceptability of trade-offs between treatment characteristics, or other attributes of treatments or health interventions.
The PREFER Recommendations provide expert and evidence-based guidance from six years of research on when and how to design and conduct a patient preference study.
The PREFER project was a joint undertaking by 33 public and private partners with more than 130 people representing academic institutions, pharmaceutical companies, health technology agencies, and patient organisations in European countries and in the US.
| Name | Size | |
|---|---|---|
|
PREFER Recommendations.pdf
md5:9e9883de428324ca5e7c1aa771dbfbc1 |
5.8 MB | Download |
| All versions | This version | |
|---|---|---|
| Views | 5,542 | 2,950 |
| Downloads | 3,729 | 2,130 |
| Data volume | 22.6 GB | 12.4 GB |
| Unique views | 4,947 | 2,703 |
| Unique downloads | 3,175 | 1,855 |
- Publication date:
- April 19, 2022
- DOI:
-
- Grants:
-
European Commission:
- PREFER - Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 (115966)
- Communities:
- License (for files):
- Creative Commons Attribution 4.0 International